PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON ITS MASITINIB PLATFORMAB Science SA(Euronext - FR0010557264 - AB) today provides an update on its masitinib platform. The webcast presentation is ...

Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...

Intracellular kinases play a ubiquitous role in signaling pathways within cells ... nonreceptor tyrosine kinases and serine/threonine protein kinases function throughout cascades, phosphorylating ...

Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.

In turn, the autophagic pathway mediates PAR1 degradation ... transient receptor potential canonical; PLC, phospholipase C; PKC, protein kinase C; CaMKKB, calcium/calmodulin-dependent protein kinase ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming ...

DelveInsight’s c-MET-NSCLC pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity, today announced that it has secured a $30 million ...

New research has identified crucial components and mechanisms of the plant immune system, potentially helping to develop ...